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The progression of chronic kidney disease is a complex
process influenced by genetic factors. Proteinuria is a
predictor of functional deterioration and an accelerator of
disease progression through renal parenchymal damage and
interstitial fibrosis. To determine genetic components that
might mediate renal fibrosis due to proteinuria, we mapped
loci influencing the phenotype of two mouse strains differing
in proteinuria-induced renal type I collagen (COLI)
deposition. Collagen I deposition in 129S1/svImJ and
C57BL/6J mice differs significantly among tested strains.
We backcrossed 120 hemi-nephrectomized (129S1/
svImJC57BL/6J) F1 129S1/svImJ backcrossed mice
loaded with bovine serum albumin giving rise to proteinuria
and renal COLI deposition. Quantitative trait loci (QTL)
mapping was performed and our analysis identified one
suggestive linkage for renal COLI deposition peaking at
87 cM near D2Mit224 (logarithm of odds: 2.41) on Chr 2.
In silico analysis uncovered nine candidate genes. Hence,
although more studies are needed, these QTL provide an
initial cue to subsequent gene discovery, which might help
unravel the genetics of renal fibrosis.
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Spreading of parenchymal damage is central to processes by
which nephropathies of different types progress to end-stage
renal disease (ESRD).1 Baseline proteinuria is an independent
predictor of renal outcome and risks for cardiovascular
mortality in patients with diabetic as well as non-diabetic
nephropathies.2–4 In the Ramipril Efficacy in Nephropathy
trial, the renoprotection conferred by angiotensin-converting
enzyme inhibition was mediated by reducing urinary protein
levels, and the rate of renal functional deterioration correlated
negatively with proteinuria reduction and positively with
residual proteinuria.2 In addition, in proteinuric, progressive
glomerular diseases, a number of clinicopathological studies
have demonstrated that renal interstitial fibrosis is not merely
a consequence of glomerulosclerosis, and the degree of
interstitial fibrosis has a significantly greater impact on renal
functional outcome than glomerular damage per se.5 When
viewed in combination, there seem to be some mechanistic
links between proteinuria and renal interstitial fibrosis.
Proteinuria contains a variety of serum proteins and renal
tissue-derived factors that are likely involved in tubular
activation and subsequent fibrogenesis.5 Albumin uptake by
endocytosis initiates various signal-transduction cascades in
tubular epithelial cells, and subsequent activation of phos-
phatidylinositide 3-kinase and protein kinase C likely
activates nicotinamide adenine dinucleotide phosphate
oxidase and generates reactive oxygen species such as
superoxide and hydrogen peroxide (H2O2). Through H2O2
generation, albumin per se stimulates mitogen-activated
protein kinase signaling and upregulates activities of the
nuclear factor-kB and Janus kinase–signal transducers and
activator of transcription pathways in tubular epithelial cells,
thereby inducing expression of several factors, including
complement components;6 vasoactive substances such as
endothelin-1;7 adhesion molecules such as osteopontin,
intercellular adhesion molecule-1, and vascular cellular
adhesion molecule-1;8,9 and cytokines such as transforming
growth factor-b1, monocyte chemoattractant protein-1,
RANTES (regulated upon activation, normal T cell expressed
and secreted), interleukin-8, and fractalkine;10–14 to cause
renal damage in response to proteinuria. However, all of
these feasible mechanisms are highly suspected but not
proved to be involved in interstitial fibrosis in the
proteinuric, progressive glomerular diseases.
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One of the most important risk factors for chronic kidney
disease and its progression in an individual is the presence of
a family history of ESRD,15,16 suggesting genetic factors can
participate in such mechanisms. At present, except for some
monogenic forms of kidney disease, for example, polycystic
kidney disease,17,18 congenital nephrotic syndrome,19 focal
segmental glomerulosclerosis,20 very few causal genes have
been identified. However, familial clustering of disparate
causes of ESRD, including families with members having
nephropathy associated with type II diabetes mellitus,21
hypertension,22 systemic lupus erythematosus (SLE),23 and
human immunodeficiency virus infection,24 has been
reported by several groups. In particular, attention has been
paid to the correlations between the development and the
progression of IgA nephropathy and single-nucleotide
polymorphisms in genes that encode nephritis-related
molecules.15,25,26
Therefore, in this study, we performed quantitative trait
loci (QTL) analysis to search for genes associated with type I
collagen (COLI) deposition in the kidney, an early indicator
of renal fibrosis, in response to excess urinary protein
excretion. QTL analysis has been used to reveal the genetics
of chronic kidney disease using animal models.27 First, we
identified mouse strains showing the highest and the lowest
increase in an amount of COLI in the kidney in response to
urinary protein excretion. Second, quantitative linkage
analysis was performed using Map Manager QTX software
(version b20) to map QTL of susceptibility of such COLI.
RESULTS
COLI deposition in the kidney in response to urinary protein
excretion
The urinary protein excretion rate in response to loading of
bovine serum albumin (BSA) was increased in each inbred
strain by day 14, and the urinary protein excretion rate in
male mice, which was higher than that in female mice, was
not significantly different among the employed strains
(Table 1). In contrast, the increases in COLI deposition in
the kidney of male mice were not significantly different from
those of female mice in each strain. The increase in COLI
deposition in the kidney was consistently highest in 129S1/
svImJ mice (0.987±0.358 ng mg1) and lowest in C57BL/6J
mice (0.087±0.029 ng mg1) (Table 1 and Figure 1). Mice
were treated with BSA for 6 weeks in this study because of the
possible establishment of anti-BSA immunity after week 6
(data not shown), and neither severe interstitial fibrosis nor
renal functional impairment had developed by that time. In
the next experiment (129S1/svImJC57BL/6J), F1 offspring
showed a phenotype of COLI deposition slightly higher than
that of C57BL/6J mice, and significantly lower than that of
129S1/svImJ mice (0.944±0.394 ng mg1, 129S1/svImJ mice;
0.187±0.061 ng mg1, F1 mice; 0.099±0.032 ng mg1,
C5BL/6J mice), indicating that there were dominant effects
with additive ones by the alleles of 129S1/svImJ mice on
C57BL/6J mice (Figure 2). Therefore, to detect dominant
effects by at least some of the major QTL for COLI
deposition in the kidney in response to urinary protein
excretion, we produced backcross (BC) progenies of (129S1/
svImJC57BL/6J) F1 129S1/svImJ for subsequent analysis
and searched for dominant and additive effects by using Map
Manager QTX software.28,29 As urinary protein/creatinine
ratios were not significantly different between each inbred
strain or between F1 mice and their parental strain mice
(Table 1), we did not employ it as an additional quantitative
phenotype in this study. On the basis of the standard
approximation,28 the number of progenies required for QTL
detection was calculated to be 120. As there were no
significant differences between COLI deposition in removed,
native kidneys and remnant kidneys in mice treated with
saline alone (data not shown), the former were used as the
control in the subsequent experiments. One hundred and
twenty BC progenies showed varying degrees of COLI
deposition in their kidneys, and did not segregate into the
129S1/svImJ and C57BL/6J types (Figure 3), suggesting that
this phenotype was influenced by multiple genetic loci.
Table 1 | Urinary protein excretion and renal COLI deposition
in inbred mouse strains
Strain
No.
(F/M)
Urinary protein/
creatinine at
week 2
(male mice)
Increasesa in COLI
deposition in the
kidneys (ng per mg
kidney weight)
129S1/svImJ 4/5 67.0±22.0 0.987±0.358
CBA/J 5/5 80.1±20.2 0.821±0.331
SJL/J 4/4 74.1±15.5 0.695±0.299
DBA/2J 4/4 66.5±8.5 0.622±0.273
A/J 4/5 68.8±23.3 0.431±0.188
C3H/HeJ 5/5 84.3±30.2 0.397±0.154
Balb/cByJ 4/5 71.8±24.6 0.325±0.108
FVB/N 4/5 86.4±20.9 0.161±0.061
C57BL/6J 4/4 81.0±22.6 0.087±0.029
BSA, bovine serum albumin; COLI, type I collagen; F, female; M, male.
aDifferences between renal COLI deposition in the mice treated with BSA and those
with saline alone.
a b c
129S1/svImJ_D42
after BSA Tx
C57BL/6J_D42
after BSA Tx
129S1/svImJ_D0
before BSA Tx
Figure 1 | Immunofluorescence of COLI in the kidney. The COLI
signals were observed mainly at the peritubular interstitium in
the kidney of (a) 129S1/svImJ mice after 6 weeks of BSA treatment,
(b) while those of C57BL/6J mice after BSA treatment and
(c) control 129S1/svImJ mice were negligible (FITC  200).
FITC, fluorescein isothiocyanate.
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QTL analysis
At first, QTL analysis was performed with phenotypes from
the 120 recombinant BC progenies and their genotypes by
using 80 Mit markers found to be different between 129S1/
svImJ and C57BL/6J mice and which spanned the mouse
genome at an average interval of 20 cM. A peak of suggestive
QTL was found only on Chr 2, and no other significant and
suggestive QTLs were detected (data not shown). Then,
further fine genotyping of Chr 2 was performed by using
additional Mit markers reported to be polymorphic between
129S1 and C57BL/6 mice (Figure 4). In the repeated QTL
analysis, suggestive likelihood ratio statistics (LRS)X6.2, and
significant LRS412.0 were defined by 10 000 permutation
testing. LRS was converted into logarithm of odds (LOD) by
dividing by 4.61. Finally, a suggestive QTL was identified on
Chr 2, and the LRS (LOD) score peak 11.1 (2.41) with a 95%
confidence interval of 72–91 cM was located at 87 cM near
D2Mit224 (128 979 913–128 980 026 bp) (Figure 4). This
locus accounts for 9% of the total variance in COLI
deposition in the kidney in response to urinary protein
excretion. Map Manager QTX software also revealed that this
QTL had additive effects (Figure 4), which was suggested in
Figure 2. As the COLI deposition in the BC mice was not
normally distributed (Figure 3), we reanalyzed these data on
a logarithmic scale and found that such a conversion did not
yield substantial improvement in the QTL mapping. Figure 5
shows the allele effects that demonstrate the magnitude of the
effect and the inheritance pattern. Overall, the BC progenies
resulting from the F1 mice backcrossed to 129S1/svImJ mice
showed increased COLI deposition in the kidney in response
to urinary protein excretion compared with their F1 parents,
suggesting that the 129S1/svImJ genetic contribution accele-
rates COLI deposition. At the D2Mit224 locus around
which we mapped the QTL in this study, animals with a
homozygous 129S1/svImJ genotype yielded greater COLI
deposition in the kidney on average compared with their
littermates with heterozygous genotypes (Figure 5). There-
fore, the 129S1/svImJ allele appears to be more efficient in the
homozygous state, suggesting that it is a recessive allele,
whereas the C57BL/6J allele seems dominant against the
129S1/svImJ allele.
DISCUSSION
Albumin is the major component of urinary protein, and is
well recognized as a marker of renal diseases, particularly
glomerular diseases. Recently, clinical and experimental
findings suggest that albuminuria is not merely a sign of
glomerular disease, but that it also causes renal parenchymal
damage.30,31 Although the molecular mechanisms linking
urinary protein excretion and interstitial fibrosis remain to be
clarified, some hypotheses have been proposed. Albumin
uptake activates various signal-transduction cascades, such as
mitogen-activated protein kinases, phosphatidylinositide
3-kinase, Akt, Janus kinase–signal transducers and activator
of transcription, nuclear factor-kB, and activator protein-1
through oxidative stress in proximal tubular epithelial
cells,14,32–35 and results in dramatic changes in gene
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Figure 2 | Increases in COLI deposition in the kidney after BSA
treatment among parental strains. The COLI deposition in the
kidney of 129S1/svImJ mice (0.944±0.394 ng mg1) was significantly
higher than that of C57BL/6J mice (0.099±0.032 ng mg1).
(129S1/svImJC57BL/6J) F1 offspring showed a phenotype
(0.187±0.061 ng mg1) largely similar to that of C57BL/6J mice.
*Po0.05 versus 129S1/svImJ.
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Figure 3 | Frequency distribution of increases in COLI deposition
in the kidney (phenotype) in 120 F1BC progenies. The phenotypes
were obtained using differences between COLI deposition in each
remnant kidneys of BC mice treated with BSA and the relevant, native
kidneys removed before BSA loading.
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Figure 4 | QTL mapping in the 120 F1BC progenies on Chr 2. The
peak LRS (LOD) score reached 11.1 (2.41) around D2Mit224. The
vertical dotted and broken lines indicate the thresholds for
suggestive and significant linkages of the LRS scores (6.2 and 12.0),
respectively.
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expression.36 Not only pure albumin but also other molecules
in the urine such as immunoglobulins,8 complement,37
transferrin,38 cytokines,39 and lipids bound to albumin40
have been presumed to be involved in proteinuria-related
parenchymal damage in the kidney. Although the microarray
analysis detected diverse changes in gene expression in the
kidneys of proteinuric mice,36,41,42 the main pathways
through which proteinuric nephropathies progress to ESRD
remain to be clarified. Therefore, to identify genes promot-
ing/suppressing renal fibrosis, a histopathological feature of
ESRD, in response to proteinuria, we performed QTL
analysis using inbred mouse strains whose kidneys are
susceptible and resistant to urinary protein excretion, and a
suggestive QTL (peak LRS (LOD) score: 11.1 (2.41)) was
mapped around D2Mit224 on mouse Chr 2. The susceptible
and resistant inbred mouse strains determined in this study,
129S1/svImJ and C57BL/6J, respectively, gave rise to results
that were consistent with those reported from other
laboratories.43–45 In contrast, a recent report described that
C57BL/6 mice as well as 129S1/sv mice were resistant to
interstitial fibrosis in the diabetic nephropathy model
where CD-1 mice were highly susceptible,46 suggesting that
genetic background independently affects particular disease
processes.
On the basis of the mouse genome database available from
the Ensembl Genome Browser (http://www.ensembl.org/
Mus_musculus/index.html), the number of genes existing
within the candidate interval defined to contain the QTL
(125 000 000–144 000 000 bp, approximately) was 173.
Among these, the mouse gene expression profile database
available from GNF SymAtlas (http://symatlas.gnf.org/SymA-
tlas/) identified 48 genes expressed in the adult mouse kidney.
Alternatively, 40 genes among 173 genes within the interval
were suggested to be related to keywords ‘type I collagen’
and/or ‘fibrosis’ after a full-text search of the document
database (for example, MEDLINE) by PosMed (http://
omicspace.riken.jp/PosMed/). Finally, nine genes (fibrillin 1,
COP9 homolog subunit 2, adrenergic receptor alpha 2b,
prominin 2, myelin and lymphocyte protein, c-Mer proto-
oncogene tyrosine kinase, oxytocin, CDP-diacylglycerol synthase
2, and jagged-1) were simultaneously identified (Table 2).
In silico analysis with the Ensembl Genome Browser
identified non-synonymous coding single-nucleotide poly-
morphisms different between 129S1/svImJ and C57BL/6J
mice; T/C on 124 993 328 bp in fibrillin 1; A/G on
127 055 685 bp in adrenergic receptor alpha 2b; A/G on
128 467 837 bp in c-Mer proto-oncogene tyrosine kinase.
Although none of these nine genes have been clinically or
experimentally shown to encode profibrotic factors in the
kidney in response to urinary protein excretion, they were
thought to be candidates of the higher possibility.
Direct evidence for the involvement of genetic factors in
renal impairment has been obtained in various animal
models. A QTL named Pur-1 for proteinuria, on the proximal
end of rat Chr 13, was identified in a BC of Buffalo rats and
(BuffaloWistar Kyoto) F1 rats,47 which is also concordant
with a lupus nephritis susceptibility locus (Sle1) in mice.48
Jacob and co-workers identified five loci, Rf-1 through Rf-5,
involved in the development of renal impairment of fawn-
hooded hypertensive rats,49 which interactively affected
progressive proteinuria and focal segmental glomerulosclero-
sis.50–52 After Rf-1 was identified, two groups tested the
homologous human region in an African-American popula-
tion and in a Utah pedigree, which was significantly linked to
ESRD in both populations.53,54 Rf-2 on rat Chr 1 is
concordant to human Chr 19q13, which contains a gene,
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Figure 5 | Difference in increases in COLI deposition according to
the D2Mit224 genotypes. The increases in COLI deposition in
the kidney in response to urinary protein excretion were higher in
129S1/svImJ allele homozygotes than in 129S1/svImJ/C57BL/6J
allele heterozygotes. *Po0.05.
Table 2 | Candidate genes identified within the QTL (123 000 000–145 000 000 bp) on mouse Chr 2 by the Ensembl Genome
Browser, GNF SymAtlas, and PosMed
Gene_ensembl_id Gene_start Gene_end Description
ENSMUSG00000027204 124992035 125199434 Fibrillin 1
ENSMUSG00000027206 125521745 125550459 COP9 homolog, subunit 2
ENSMUSG00000058620 127054727 127058662 Adrenergic receptor alpha 2b
ENSMUSG00000027376 127147937 127232908 Prominin 2
ENSMUSG00000027375 127324669 127347724 Myelin and lymphocyte protein
ENSMUSG00000014361 128390438 128493629 c-Mer proto-oncogene tyrosine kinase
ENSMUSG00000027301 130267614 130268429 Oxytocin
ENSMUSG00000058793 131954589 132003491 CDP-diacylglycerol synthase 2
ENSMUSG00000027276 136772899 136807772 Jagged 1
QTL, quantitative trait loci.
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ACTN4, underlying a monogenic form of focal segmental
glomerulosclerosis.20 In addition, the homologous region in
the mouse is linked to glomerulonephritis susceptibility in a
model for SLE (Sle3).48 In one case of interstitial fibrosis,
linkage analysis using Munich Wistar Froemter rats identified
a genetic link between early onset of albuminuria and
progression of interstitial fibrosis at the QTL named RNO6
located at D6Mit8 (97 561 874–97 562 072 bp) on rat Chr
6q24,55 of which genetic synteny in the mouse is not the
present Chr 2 locus. One possible reason for this is that
RNO6 is an interstitial fibrosis QTL in spontaneous,
idiopathic nephropathy, whereas the present QTL are linked
to renal COLI deposition by experimental, forced urinary
protein excretion. The present QTL on mouse Chr 2 are also
clearly different from either the hepatic fibrosis susceptibility
locus on mouse Chr 15 (Hfib1)56 or the pulmonary fibrosis
susceptibility locus on mouse Chr 17 (Blmpf1).57 Alterna-
tively, human Chr 2q11.2, 2q13, Chr 15q15.3, 15q21.1,
15q21.2, and Chr 20p12.1, 20p12.2, 20p12.3, 20p13, and rat
Chr 3q35, 3q36, 3q41 are found to be genomic loci syntenic
to this mouse Chr 2 locus (Ensembl Genome Browser).
Although a search in the OMIM Database (http://
www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM) did not iden-
tify any kidney disease-related genes in these human genomic
loci, a Rat Genome Database search (http://rgd.mcw.edu/)
found three renal QTL, for example, Rf11 at D3Rat11, Rf12 at
D3Rat169, and Kidm4 at D3Rat6, on these rat Chr 3 loci,
which were related to abnormal renal plasma flow, glomeru-
lar morphology, and kidney size under a high-salt diet and
administration with norepinephrine or angiotensin II,
respectively, but not to renal fibrosis.58 Despite some
exceptions, the finding that kidney disease QTL in rats are
concordant with kidney disease loci in mice and humans
suggests that conserved disease genes may underlie these
QTL, implying that comparative genomics can identify
conserved loci underlying kidney disease. We believe that
combining the knowledge obtained in the three different
species is a powerful means to reveal the genetics of chronic
kidney disease.
In conclusion, a suggestive QTL for COLI deposition in
the kidney in response to urinary protein excretion was
mapped around D2Mit224 on mouse Chr 2. Nine genes
localized within this region were suggested as candidate genes
by in silico identification methods. In addition to the
fulfillment of the major criteria for QTL gene discovery
established by the Complex Trait Consortium,59 further
studies are needed to focus on the functional differences in
these molecules, particularly with regards to the regulatory
and coding single-nucleotide polymorphisms that differ
between 129S1/svImJ and C57BL/6J mice. Such information
will highlight the molecular mechanisms linking urinary
protein exposure to tubular epithelial cells and COLI
deposition in the interstitial space, and may provide cues
to establish identification techniques for fibrosis-prone
individuals and antifibrosis therapies against progressive
chronic kidney disease.
MATERIALS AND METHODS
Mice
Inbred mouse strains used in this study included 129S1/svImJ, A/J,
Balb/cByJ, C3H/HeJ, C57BL/6J, CBA/J, DBA/2J, FVB/N, and SJL/J,
which were purchased from Charles River Laboratories Japan
(Yokohama, Japan). The mice were maintained on a standard diet
and tap water ad libitum. Animals were housed at 22 1C and 60%
humidity constantly with a 12/12-h light/dark cycle. Animal care
and treatment were conducted in accordance with institutional
guidelines.
Urinary protein excretion model
Urinary protein excretion model mice were generated by the method
reported by Eddy et al.60 with a slight modification. Six-week-old
mice of each strain, male 129S1/svImJ, C57BL/6J, and F1 offspring
mice, and recombinant progenies were uninephrectomized under
anesthesia 7 days before starting BSA injections. Removed kidneys
were stored at 80 1C until analysis. Low-endotoxin BSA (A-9430;
Sigma, St Louis, MO, USA) was dissolved in saline and given daily
intraperitoneally at a dose of 10 mg per g body weight for 6 weeks.
Saline alone was used for the negative controls. Between days 14 and
16, individual mice were placed in metabolic cages, and all urine
that was spontaneously voided over a 48 h period was collected for
determination of 24 h total urinary protein excretion. Total protein
concentration in urine was measured by using a bicinchoninic acid
protein assay kit (Pierce, Rockford, IL, USA). Urinary creatinine
levels were measured by the standard Jaffe rate reaction using
alkaline picrate (Sigma). The kidney removed before BSA injections
was used as the relevant control for each individual mouse. At the
time of killing, kidneys were harvested and samples were snap-
frozen in liquid nitrogen for protein extraction and immunofluor-
escence, and tails were harvested for DNA extraction for genotyping.
COLI quantification phenotyping and immunofluorescence
Frozen kidney tissues were weighed and homogenized/sonicated
extensively in saline. The samples were then centrifuged for 5 min
(14 000 g), and protein concentration in the supernatant was
measured by using the Bradford assay. The concentration of COLI
in the supernatant was measured by indirect enzyme-linked
immunosorbent assay, as described previously.61 Each phenotype
value was determined as a difference in COLI contents (ng per mg
kidney weight) between experimental and relevant control kidneys.
In the first screening experiment using various inbred mice and the
second experiment using 129S1/svImJ, F1, and C57BL/6J mice,
remnant kidneys in the mice treated with saline alone were used as
control kidneys. In the third experiment using the BC mice, each
removed, native kidneys were used as relevant control kidneys.
Indirect immunofluorescence was performed on 4 mm cryostat
kidney sections, as described previously.62 Rabbit anti-COLI anti-
body (1:500; Calbiochem, San Diego, CA, USA) was employed as the
primary antibody, and followed by fluorescein isothiocyanate-
conjugated goat anti-rabbit IgG antibody (1:500; American Qualex,
San Clemente, CA, USA) as the secondary antibody.
PCR genotyping
PCR was performed by standard techniques on genomic DNA
extracted from tail snips. The tail samples were digested with
proteinase K, extracted with phenol/chloroform/isoamyl alcohol,
and the DNA was precipitated by ethanol. Each sample was then
resuspended in 3 ml of dH2O and stored at 4 1C. If an excess of DNA
was present, samples were diluted 1:5 with dH2O. We genotyped 120
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BC progenies initially with 80 Microsatellite Mit markers from the
Whitehead Institute/MIT Center for Genetic Research website
(http://www.genome.wi.mit.edu) that were spaced at approximately
20 cM intervals throughout the genome and showed polymorphisms
between 129S1/svImJ and C57BL/6J mice, and later added five
additional Mit markers around the QTL region on Chr 2. PCR
conditions were independently determined for each set of Mit
markers. Most of the PCR primer sets were purchased from
Invitrogen (Carlsbad, CA, USA). In general, 5 ml of DNA was used in
each 20 ml reaction, with annealing temperatures between 50 and
65 1C, 1 min extension time, for 35 cycles. PCR products were
resolved on a 5% horizontal agarose gel containing 2/3 low melting
point and 1/3 standard agarose and were stained with ethidium
bromide. Control DNA from both parental strains as well as from an
F1 offspring were run with each marker. Primer and PCR
information is available upon request.
Quantitative linkage analysis
Male 129S1/svImJ mice were mated with female C57BL/6J mice, and
opposite mating was performed to obtain (129S1/svImJC57BL/
6J) F1 offspring for both combinations, and quantitative phenotyp-
ing was performed. The F1 mice were backcrossed to 129S1/svImJ
mice to generate a total of 120 BC progenies. By using phenotypic
and genotypic data of these progenies, QTL mapping was performed
with increases in COLI deposition in the kidney as quantitative
traits using Map Manager QTX version b20 obtained from http://
www.mapmanager.org/mmQTX.html. To minimize a-error, LRS
(LOD) scores of 6.2 (1.3) and 12.0 (2.6) were defined by 10 000
permutation testing and used as thresholds for suggestive and
significant linkage, respectively.
Statistical analysis
Values are presented as the means±s.e. Statistical differences
between groups were evaluated using a Bonferroni/Dunnett’s
test; P-values o0.05 were considered to be statistically
significant.
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